D. E. Shaw & Co., Inc. Amphastar Pharmaceuticals, Inc. Put Options Transaction History
D. E. Shaw & Co., Inc.
- $156 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
271Shares Held
33.9MCall Options Held
76.6KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$68.6 Million0.0% of portfolio
-
Td Asset Management Inc1.93MShares$50.3 Million0.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.76MShares$45.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.5MShares$39.1 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.28B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...